June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Intranasal Neurostimulator Induces Morphologial Changes in Meibomian GLands in Patients with Dry Eye Disease
Author Affiliations & Notes
  • Nicholas Pondelis
    Cornea Service, New England Eye Center, Boston, Massachusetts, United States
    Center for Translational Ocular Immunology, Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Gabriella Dieckmann
    Cornea Service, New England Eye Center, Boston, Massachusetts, United States
    Center for Translational Ocular Immunology, Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Paula Kataguiri
    Cornea Service, New England Eye Center, Boston, Massachusetts, United States
    Center for Translational Ocular Immunology, Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Alessandro Abbouda
    Cornea Service, New England Eye Center, Boston, Massachusetts, United States
    Center for Translational Ocular Immunology, Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • zeina salem
    Cornea Service, New England Eye Center, Boston, Massachusetts, United States
    Center for Translational Ocular Immunology, Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Manfred Franke
    Research and Development, Allergan, Irvine, California, United States
  • Michelle Senchyna
    Director, Product Enhancement, Allergan, Irvine, California, United States
  • Pedram Hamrah
    Cornea Service, New England Eye Center, Boston, Massachusetts, United States
    Center for Translational Ocular Immunology, Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Nicholas Pondelis, None; Gabriella Dieckmann, None; Paula Kataguiri, None; Alessandro Abbouda, None; zeina salem, None; Manfred Franke, Allergan (E); Michelle Senchyna, Allergan (E); Pedram Hamrah, Allergan (C), Allergan (F), Eyegate Pharmaceuticals (C), GlaxoSmithKline (C), GlaxoSmithKline (F), Heidelberg Engineering (C), Jade Pharmaceuticals (C), Novabay (C), Santen Inc. (C), Shire (C), Shire (F), Stemnion (C), Tissue-Tech (C), Tissue-Tech (F), Valeant (C)
  • Footnotes
    Support  Allergan, Inc., Irvine, CA; NIH R01-EY022695; Massachusetts Lions Eye Foundation
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 2235. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Nicholas Pondelis, Gabriella Dieckmann, Paula Kataguiri, Alessandro Abbouda, zeina salem, Manfred Franke, Michelle Senchyna, Pedram Hamrah; Intranasal Neurostimulator Induces Morphologial Changes in Meibomian GLands in Patients with Dry Eye Disease. Invest. Ophthalmol. Vis. Sci. 2017;58(8):2235.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The Intranasal Tear Neurostimulator (ITN) delivers a small electrical current to sensory neurons of the nasal cavity that stimulate the nasolacrimal reflex to induce tear production. Most patents with dry eye (DE) suffer from decreased tear break-up time with varying degrees of meibomian gland (MG) dysfunction. Meibum expression is typically achieved though coordinated muscular activity of the orbicularis and Riolan’s muscles, both of which are innervated by the cranial nerve CN-VII. This study explored whether MG morphology was altered following use of the ITN.

Methods : Twelve DE subjects were enrolled in a single-center, single-arm study. Anterior segment optical coherence tomography (AS-OCT) meibography was performed on the lower eyelids of each patient before and after approximately 3 minutes of ITN stimulation. Central MGs clearly shown in both sets of AS-OCT images were selected for analysis. The same MGs were selected before and after stimulation. In the selected images three or four glands were analyzed. The MGs were selected according to the accuracy and quality from the image. Two masked observers then analyzed images using ImageJ™ software. The area and perimeter of selected MGs were quantified, and the effect of ITN on MGs was determined by morphological changes after stimulation. All data are shown as mean±SD. Mean data were compared using a paired t-test. P values <0.05 were considered statistically significant.

Results : Mean pre- and post-stimulation MG areas were 2,184.76±135.51µm2 and 1,933.2±114.82mm2, respectively. The mean change in area, 251.56±20.69 µm2, representing a 11.6% reduction following use of the ITN, was statistically significant (p<0.001). Mean pre- and post-stimulation MG perimeters were 222.2±10.14 µm and 235.9±10.95mm, respectively. The mean change in perimeter, 13.7±0.81 µm, representing a 5.81% reduction following use of the ITN, was statistically significant (p<0.012). The images after use of the INT showed an increase in brightness at the conjunctival surface, and hyporeflective areas at orifices of the MGs suggesting release of meibum.

Conclusions : In addition to lacrimal gland stimulation, use of the ITN has a significant effect on MG morphology. Post-ITN use, MGs were measurably reduced in area and perimeter, suggesting release of meibum.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×